8
Cat No. | Product Name | Synonyms | Targets |
---|---|---|---|
T3402 | 20(S)-Ginsenoside Rg3 | 20(S)-Ginsenoside-Rg3,Rg3,20S-Ginsenoside Rg3,Ginsenoside Rg3,S-Ginsenoside Rg3 | EGFR , Beta Amyloid , Potassium Channel , NF-κB , COX , Sodium Channel , Endogenous Metabolite |
20(S)-Ginsenoside Rg3 (Rg3) possess an ability to inhibit the lung metastasis of tumor cells via inhibition of the adhesion and invasion of tumor cells. It inhibits the proliferation of human umbilical vein endothelial c... | |||
T3812 | (20R)-Ginsenoside Rg3 | 20(R)-Ginsenoside Rg3,(20R)Ginsenoside Rg3,20(R)-Propanaxadiol | Others |
(20R)-Ginsenoside Rg3 (20(R)-Propanaxadiol) is a compound with anti-aging and antifatigue activities. | |||
T3336 | Rg3039 | PF-06687859 | Others |
Rg3039 (PF-06687859) is a potent DcpS inhibitor. DcpS is a therapeutic target for spinal muscular atrophy. Spinal muscular atrophy (SMA) is caused by deletion or mutation of both copies of the SMN1 gene which produces an... | |||
T83757 | RG33 TFA | ||
RG33, a synthetic 33-amino acid peptide, matches the sequence of amino acids 209-219 and 220-241 found in the C-terminal domain class Y helices of apolipoprotein A1 (ApoA1). This compound has the ability to solubilize mu... | |||
T81286 | RG33 Peptide | ||
RG33 Peptide, utilized in type 2 diabetes (T2D) research [1], enhances glucose clearance in insulin-resistant mice and facilitates cholesterol efflux in cultured macrophages by effectively solubilizing lipid vesicles. | |||
T12319 | Org30958 | Aromatase | |
Org30958 is a potent inhibitor of aromatase in vivo. | |||
T23112 | Org37684 | Org 37684 | Others |
5-HT2 receptors agonist | |||
T3S1513 | (20R)-Protopanaxadiol | Protopanaxadiol,20R-Protopanaxadiol,(20R)-Protopanaxdiol | Others , Antibacterial |
1. (20R)-Protopanaxadiol ((20R)-Protopanaxdiol) has the effect of anti-tumor through increasing the activity of body immunity, inhibiting tumor interstitial microvascular density and its proliferation activity, improving... |